These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37738672)

  • 41. Misspecified regression model for the subdistribution hazard of a competing risk.
    Latouche A; Boisson V; Chevret S; Porcher R
    Stat Med; 2007 Feb; 26(5):965-74. PubMed ID: 16755533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A dependent Dirichlet process model for survival data with competing risks.
    Shi Y; Laud P; Neuner J
    Lifetime Data Anal; 2021 Jan; 27(1):156-176. PubMed ID: 33044613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient death as a censoring event or competing risk event in models of nursing home placement.
    Szychowski JM; Roth DL; Clay OJ; Mittelman MS
    Stat Med; 2010 Feb; 29(3):371-81. PubMed ID: 20014354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Applying competing risks regression models: an overview.
    Haller B; Schmidt G; Ulm K
    Lifetime Data Anal; 2013 Jan; 19(1):33-58. PubMed ID: 23010807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified.
    Grambauer N; Schumacher M; Beyersmann J
    Stat Med; 2010 Mar; 29(7-8):875-84. PubMed ID: 20213713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use and interpretation of competing risks regression models.
    Dignam JJ; Zhang Q; Kocherginsky M
    Clin Cancer Res; 2012 Apr; 18(8):2301-8. PubMed ID: 22282466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards.
    Beyersmann J; Dettenkofer M; Bertz H; Schumacher M
    Stat Med; 2007 Dec; 26(30):5360-9. PubMed ID: 17634974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models.
    Zhang X; Zhang MJ
    Comput Methods Programs Biomed; 2011 Jan; 101(1):87-93. PubMed ID: 20724020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A competing risks model for correlated data based on the subdistribution hazard.
    Dixon SN; Darlington GA; Desmond AF
    Lifetime Data Anal; 2011 Oct; 17(4):473-95. PubMed ID: 21603882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
    Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
    Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety analysis of new medications in clinical trials: a simulation study to assess the differences between cause-specific and subdistribution frameworks in the presence of competing events.
    Genet A; Bogner K; Goertz R; Böhme S; Leverkus F
    BMC Med Res Methodol; 2023 Jul; 23(1):168. PubMed ID: 37442979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of two treatments in the presence of competing risks.
    Lyu J; Chen J; Hou Y; Chen Z
    Pharm Stat; 2020 Nov; 19(6):746-762. PubMed ID: 32476264
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The number of primary events per variable affects estimation of the subdistribution hazard competing risks model.
    Austin PC; Allignol A; Fine JP
    J Clin Epidemiol; 2017 Mar; 83():75-84. PubMed ID: 28088594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Missing covariates in competing risks analysis.
    Bartlett JW; Taylor JM
    Biostatistics; 2016 Oct; 17(4):751-63. PubMed ID: 27179002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution.
    Katsahian S; Resche-Rigon M; Chevret S; Porcher R
    Stat Med; 2006 Dec; 25(24):4267-78. PubMed ID: 16960919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Model selection in competing risks regression.
    Kuk D; Varadhan R
    Stat Med; 2013 Aug; 32(18):3077-88. PubMed ID: 23436643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates.
    Sapir-Pichhadze R; Pintilie M; Tinckam KJ; Laupacis A; Logan AG; Beyene J; Kim SJ
    Am J Transplant; 2016 Jul; 16(7):1958-66. PubMed ID: 26751409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variable selection in subdistribution hazard frailty models with competing risks data.
    Ha ID; Lee M; Oh S; Jeong JH; Sylvester R; Lee Y
    Stat Med; 2014 Nov; 33(26):4590-604. PubMed ID: 25042872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simulating competing risks data in survival analysis.
    Beyersmann J; Latouche A; Buchholz A; Schumacher M
    Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.